Add like
Add dislike
Add to saved papers

Auxilliary Liver Transplantation According to the RAPID Procedure in Non-cirrhotic Patients - Technical Aspects and Early Outcomes.

Annals of Surgery 2022 October 14
OBJECTIVE: To present technical details and short-term experiences of Liver transplantation as a two-stage procedure using small for size grafts in a multicenter cohort study.

SUMMARY BACKGROUND DATA: Two-stage liver transplantation using small for size grafts should be a feasible procedure with lower morbidity and mortality rates. Retrospective cohort study between 2015 and 2022 with multicenter experience. Twenty-three RAPID procedures for non-cirrhotic indications were performed in six European centers (twenty with grafts from living donors and three after deceased donation). Procedure´s feasibility, graft volumetric changes, morbidity and mortality of donor and recipient were explored.

RESULTS: There was a low donor morbidity (4.3 %) in our cohort. Hypertrophy of the graft was rapid (mean graft volume increases 107% between both stages) and offered the opportunity for remnant-hepatectomy after a median of 14 days. In all cases, porto-mesenteric flow was routed to the graft by right remnant portal vein ligation. Portal vein inflow modulation to alleviate transient harmful portal hypertension was not needed in any case. Early postoperative mortality (4.3 %) of the recipients were low. Ten patients suffered from complications ≥IIIb according to the Clavien-Dindo classification.

CONCLUSION: Two-stage liver transplantation is a feasible option for non-cirrhotic patients allowing the safe use of small for size grafts and could possibly be extended with caution to liver diseases with portal hypertension and cirrhosis. The RAPID technique might be a viable option for expanding the donor pool given the current organ shortage especially for low-MELD patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app